Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
LEXINGTON, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company ...
news.stocktradersdaily1d
When (KROS) Moves Investors should Listen
Check the time stamp on this data. Updated AI-Generated Signals for Keros Therapeutics Inc. (KROS) available here: KROS. Type a few symbols and Take a Trial. The signals for these will appear ...
Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
The Nation UAE on MSN1d
CDWP clears 16 development projects worth Rs259.68b
The Central Development Working Party (CDWP) has given nod to 16 development projects worth Rs259.68 billion. The CDWP, which met with Federal Minister PDSI and Deputy Chairman Planning Commission ...
Investornewsbreaks Kairos Pharma Ltd. (NYSE American: KAPA) To Present At AACR-JCA Joint Conference On Innovative Cancer Therapy
Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, announced it will present during the plenary session of the 13th AA ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Keros Therapeutics, Inc. (KROS) And Encourages Shareholders to Connect
NEW YORK, NY / ACCESS Newswire / January 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Here's Why We're Not Too Worried About Keros Therapeutics' (NASDAQ:KROS) Cash Burn Situation
Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So should Keros Therapeutics (NASDAQ:KROS) shareholders be worried about its cash burn?
CDWP Approves 16 Projects Worth Rs. 260 Billion
Minister for Planning Ahsan Iqbal chaired a meeting of the Central Development Working Party (CDWP) which approved 16 development projects worth Rs.